Final toxicity results of a radiation-dose escalation study in patients with non–small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis
about
Radiation dose effect in locally advanced non-small cell lung cancerExtracting the normal lung dose-response curve from clinical DVH data: a possible role for low dose hyper-radiosensitivity, increased radioresistance.A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data.Using patient data similarities to predict radiation pneumonitis via a self-organizing mapThe lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome.Feasibility of omitting clinical target volume for limited-disease small cell lung cancer treated with chemotherapy and intensity-modulated radiotherapy.Immunological Aspect of Radiation-Induced Pneumonitis, Current Treatment Strategies, and Future ProspectsEffect of normal lung definition on lung dosimetry and lung toxicity prediction in radiation therapy treatment planning.Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy.Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.A Dosimetric Comparison of Dose Escalation with Simultaneous Integrated Boost for Locally Advanced Non-Small-Cell Lung CancerAdaptive radiotherapy in lung cancer: dosimetric benefits and clinical outcomeNormal tissue studies in radiation oncology: A systematic review of highly cited articles and citation patterns.Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03Investigation of the support vector machine algorithm to predict lung radiation-induced pneumonitisAxitinib Improves Radiotherapy in Murine Xenograft Lung Tumors.Radiobiologically guided optimisation of the prescription dose and fractionation scheme in radiotherapy using BioSuite.Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: preliminary results of a risk-stratified phase I dose escalation studyA neural network model to predict lung radiation-induced pneumonitis.Serum toll-like receptors are potential biomarkers of radiation pneumonia in locally advanced NSCLC.Association between RT-induced changes in lung tissue density and global lung function.Dosimetric comparison between jaw tracking and static jaw techniques in intensity-modulated radiotherapy.Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy.Nondosimetric risk factors for radiation-induced lung toxicity.Soy isoflavones radiosensitize lung cancer while mitigating normal tissue injuryThe ameliorative effect of silibinin against radiation-induced lung injury: protection of normal tissue without decreasing therapeutic efficacy in lung cancer.The analysis of prognostic factors affecting post-radiation acute reaction after conformal radiotherapy for non-small cell lung cancer.Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing.The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention.Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues.Analysis of radiation pneumonitis risk using a generalized Lyman model.Radiation pneumonitis in patients with lung and mediastinal tumours: a retrospective study of risk factors focused on pulmonary emphysema.The effect of CyberKnife therapy on pulmonary function tests used for treating non-small cell lung cancer: a retrospective, observational cohort pilot studyTreatment outcome and toxicity of intensity-modulated (chemo) radiotherapy in stage III non-small cell lung cancer patients.Use a survival model to correlate single-nucleotide polymorphisms of DNA repair genes with radiation dose-response in patients with non-small cell lung cancer.X-radiation inhibits histone deacetylase 1 and 2, upregulates Axin expression and induces apoptosis in non-small cell lung cancer.The role of PDGF in radiation oncology.[18F]-FDG uptake dose-response correlates with radiation pneumonitis in lung cancer patients.Poor baseline pulmonary function may not increase the risk of radiation-induced lung toxicity.Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapy.
P2860
Q26823043-453F1157-F2F4-48E0-9E12-E01EBF2D6BE3Q30988682-6A4D09C5-2308-442F-BB97-6E466CE9E82EQ31121412-0D818324-F629-4C74-826B-B5078AA8D544Q31142281-FBCE6DF4-D286-4591-BE90-9617CD878B2BQ33532886-74BFDFB1-CFAC-4F85-BF9C-59981DBD7E0FQ33552156-D20AEB18-3837-434D-A189-F4E2F800A66CQ33621874-5682B1AD-DFC7-4A77-AC0C-4F09498334E9Q33637920-1BF06D2E-89BD-4758-BED2-69E3BCC7E76EQ33645619-52767DD3-C850-4F76-8B2B-A3C55F9BEB4AQ33743705-08272C9F-A621-4179-9553-E9F9C8302876Q33786722-C0261C9C-26B1-4725-BB6D-A80C46A722F2Q33823123-4349E9F4-B571-4C34-A655-E85AF60514A9Q33967649-681CFE99-E858-4D5E-B876-7CE6308F033DQ34033710-CCC68D9B-FC9E-4E90-A3AA-4E7FCD77A810Q34060849-853A7438-91B3-40FA-8FBD-775F93D388F4Q34092023-1072ECC0-9A81-433F-974F-CC1E24812B6AQ34211377-D03C548C-EC99-44A7-AEEF-9B6B5250DA3FQ34610601-D1258933-FDCC-481A-9402-B88BE2DECECDQ34699983-69D8E9E7-E549-4BC8-915D-211DF9E2BCA5Q34733049-27268515-9A3A-4F61-95E7-2C127B814CC4Q34870652-E6BD821D-41D0-48D7-989A-68CC7A778E8EQ35079284-36DD74AA-A16B-47B4-8CFC-5EE4BFFBF5B3Q35273018-D97B6449-82A4-4A0D-B8AC-89026C4C0265Q35456001-04AC750D-1761-4568-A152-50BBAE820C61Q35588229-566A79F9-F745-4C58-BA7A-1F86574A59BCQ35682826-816D5172-FDAF-4700-81C7-6C5CACDFD35FQ35817771-94EDF8EA-49E8-43F6-88CF-E6029E2082EEQ36054772-EBDB0C47-8A3C-4D1D-9270-042E66C2B561Q36077772-D2068E27-4586-4C08-9A8C-89DB2907B7D1Q36202855-0197F961-CEC8-48E2-8B58-5FB8B64FE49AQ36235629-389B83A6-72AD-4A88-B481-CAED3AC1762DQ36325572-449EEB0C-6CFA-4869-BD89-ECE11ECBB096Q36326386-A966C9CD-55E1-424E-B530-5704C84EB695Q36384058-E4BEE949-EDD6-467A-82E9-0BB6166CEB19Q36433810-46C15DC3-3465-4CBC-93A5-54CE8F617167Q36524116-07BE4C10-90D5-4CBB-81A4-EA283FDD862AQ36705396-1F97106C-4AC7-4EE1-A799-8BF949B6F826Q36766549-10A9A9F2-8C36-4253-8370-E41B3A9A1D74Q36821497-1F7BD068-3067-410F-9012-3802A6C9AAC0Q36821511-147DFFDA-9A30-427C-ABD0-7FE8A7F68118
P2860
Final toxicity results of a radiation-dose escalation study in patients with non–small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis
description
article
@en
im Juli 2006 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2006
@uk
name
Final toxicity results of a ra ...... ation pneumonitis and fibrosis
@en
Final toxicity results of a ra ...... ith non–small-cell lung cancer
@nl
type
label
Final toxicity results of a ra ...... ation pneumonitis and fibrosis
@en
Final toxicity results of a ra ...... ith non–small-cell lung cancer
@nl
prefLabel
Final toxicity results of a ra ...... ation pneumonitis and fibrosis
@en
Final toxicity results of a ra ...... ith non–small-cell lung cancer
@nl
P2093
P1476
Final toxicity results of a ra ...... ation pneumonitis and fibrosis
@en
P2093
Allen Lichter
Andrew Turrisi
Avraham Eisbruch
Benedick Fraass
Douglas Arenberg
Feng-Ming Kong
Gregory P Kalemkerian
James A Hayman
Kent A Griffith
Theodore S Lawrence
P304
P356
10.1016/J.IJROBP.2006.01.051
P407
P577
2006-05-02T00:00:00Z